SESSION 1: IMPROVING QUALITY of LIFE PANEL 1.1B: Human Health - PowerPoint PPT Presentation

Jul 25, 2020 •4.29k likes •4.46k views

SESSION 1: IMPROVING QUALITY of LIFE PANEL 1.1B: Human Health Professor and Chairman, Osaka University Graduate School of Medicine Jun Hatazawa is Professor and Chair of Nuclear Medicine and Tracer Kinetics at Osaka University Graduate School

SESSION 1: IMPROVING QUALITY of LIFE PANEL 1.1B: Human Health Professor and Chairman, Osaka University Graduate School of Medicine Jun Hatazawa is Professor and Chair of Nuclear Medicine and Tracer Kinetics at Osaka University Graduate School of Medicine and current President of Asia Oceania Federation of Nuclear Medicine and Biology; he is engaged in the “ Atoms for Medicine ” project where Jun HATAZAWA nuclear energy is used for diagnostic imaging and Japan targeted radionuclide therapy of cancer
Nuclear medicine: Molecular medicine - a a uniq ique tool for dia iagnosis and th therapy of f dis iseases (P (Pt t I) I) Professor Jun Hatazawa IAEA Ministerial Conference on Nuclear Science and Technology, 28-30 November 2018, Vienna, Austria
Myocardial Perfusion Imaging
Amyloid Deposition in Brain Patient with Alzheimer ’ s disease Normal
Cancer Detection by Hybrid Imaging

Recommend

Innovative Pipeline Sir Andrew Witty 3 November 2015 Cautionary statement regarding

Innovative Pipeline Sir Andrew Witty 3 November 2015 Cautionary statement regarding forward-looking statements This presentation contains forward-looking statements. Forward- looking statements give the Groups current expectations or forecasts

1.7k views • 137 slides

Poster Presentation Worksheet Directions: Write one to two paragraphs for each of the two

Poster Presentation Worksheet Directions: Write one to two paragraphs for each of the two audiences below that summarizes how you would explain your poster to a visitor. Imagine yourself presenting your poster and giving a two-minute summary of

462 views • 3 slides

NA-831: a New Drug Candidate for Treatment of Alzheimers Disease Lloyd Tran CEO NeuroActiva,

NA-831: a New Drug Candidate for Treatment of Alzheimers Disease Lloyd Tran CEO NeuroActiva, Inc. Confidential do not distribute- March 14, 2018 1 NeuroActiva, Inc. is a bio-pharmaceutical company committed to discover, develop and

652 views • 18 slides

MY WHY ROBERT VICTOR VAN CAMP, DVM FEBRUARY 9TH, 1933 APRIL 7TH, 2015 My Father , Robert Victor

IDEALHEALTHUS . COM MY WHY ROBERT VICTOR VAN CAMP, DVM FEBRUARY 9TH, 1933 APRIL 7TH, 2015 My Father , Robert Victor Van Camp , 77 y . o . retired DVM , diagnosed with Alzheimer s Disease ( AD ), 2011 Family sought any / all available

739 views • 20 slides

Bioventix Presentation: 30 March 2020 Coronavirus (COVID-19) Statement & Comments We will

1 Bioventix Presentation: 30 March 2020 Coronavirus (COVID-19) Statement & Comments We will endeavour to make some comment about COVID-19 and its possible impact on Bioventix, accepting the fact that such statements can be quickly

406 views • 14 slides

The Challenge of Dementia: Prospects for Prevention A 100 year journey from discovery to

The Challenge of Dementia: Prospects for Prevention A 100 year journey from discovery to prevention trials? Alzheimer and Auguste D Amyloid Plaque Brain atrophy Neurofibrillary Tangle Dementia is not the same as Alzheimers disease

999 views • 40 slides

PAPER PRESENTATION - Sritama Mukherjee 27.08.2016 Membrane for UNIVERSAL water purifjcation?

PAPER PRESENTATION - Sritama Mukherjee 27.08.2016 Membrane for UNIVERSAL water purifjcation? Prevalent techniques: Chemical precipitation- ~99% effjciency, causes secondary pollution, expensive, treats high contamination. Sorbents

322 views • 15 slides

Severely Debilitating or Life- Threatening Hematologic Diseases John Leighton PhD Director

Severely Debilitating or Life- Threatening Hematologic Diseases John Leighton PhD Director Division of Hematology Oncology Toxicology (DHOT) Office of Hematology and Oncology Products (OHOP) Outline Applicable guidelines ICH M3

692 views • 35 slides

COR388, A NOVEL GINGIPAIN INHIBITOR, DECREASES FRAGMENTATION OF APOE IN ALZHEIMERS DISEASE

COR388, A NOVEL GINGIPAIN INHIBITOR, DECREASES FRAGMENTATION OF APOE IN ALZHEIMERS DISEASE CENTRAL NERVOUS SYSTEM Disclaimer Certain information contained in this presentation and statements made orally during this presentation relate to or

218 views • 20 slides

Developing Xanamem Presented by, Dr. Bill Ketelbey CEO & Managing Director Disclaimer

Developing Xanamem Presented by, Dr. Bill Ketelbey CEO & Managing Director Disclaimer This presentation has been prepared by Actinogen Medical Limited. ( Actinogen or the Company) based on information available to it as at

553 views • 31 slides

EU regulatory perspective on the potential use of biomarkers in AD drug development Valentina

EU regulatory perspective on the potential use of biomarkers in AD drug development Valentina Mantua, M.D. PhD EMA Workshop on Alzheimers Disease London, 24- 25 November 2014 Public Declaration of transparency/interests* More than 2 More

676 views • 15 slides

emm1 invasive Group A Streptococcus isolated from Belgian patients during 19942013 J. Coppens 1

#O226 Genome-wide longitudinal analysis of emm1 invasive Group A Streptococcus isolated from Belgian patients during 19942013 J. Coppens 1 , B. B. Xavier, J. Sabirova 1 , C. Lammens 1 , K. Loens 2 , S. Malhotra-Kumar 1 , H. Goossens 1 1

213 views • 18 slides

PRECISION NEUROLOGY CORPORATE OVERVIEW MAY 2020 ESCAPE Develops Precisely Targeted Novel

PRECISION NEUROLOGY CORPORATE OVERVIEW MAY 2020 ESCAPE Develops Precisely Targeted Novel Therapies for Genetically Defined Neurodegenerative Diseases Diverse pipeline focused on genetically defined neurodegenerative diseases Selective

2.51k views • 25 slides

Overview of History Epidemiology Concussions Recognition Cumulative Injuries CSMS April 28th

4/26/15 Concussion Overview Overview Overview of History Epidemiology Concussions Recognition Cumulative Injuries CSMS April 28th 2014 Imaging/Biomarkers David Wang MD, MS Treatment/Rehabilitation Elite Sports Medicine Prevention

552 views • 15 slides

Priavoid A life without dementia Company Presentation, BIO, June, 2017 Prof. Dr. Dieter Willbold

Priavoid A life without dementia Company Presentation, BIO, June, 2017 Prof. Dr. Dieter Willbold (co-founder and future Chairman of the Supervisory Board) The Company At a glance Established: probably in July 2017 Location: Jlich, Germany

701 views • 16 slides

Dev evel elopm pment nt of of Nov ovel el B Biothe otherap apeu eutics for for the

Dev evel elopm pment nt of of Nov ovel el B Biothe otherap apeu eutics for for the Treatm the eatmen ent of of Tauopat auopathies Panor anoram ama Res esea earch, h, I Inc nc . Innov novat ative NeuroTec echno hnologi

378 views • 18 slides

Prevent brain ageing with personalised nutrigenomics Prof. Michael Fenech University of South

Prevent brain ageing with personalised nutrigenomics Prof. Michael Fenech University of South Australia: Michael.Fenech@unisa.edu.au Genome Health Foundation: mf.ghf@outlook.com Healthy Neuron Tau tangles Diseased Neuron Amyloid plaques

774 views • 10 slides

ALZ123 The basics of Alzheimers and other dementia-related illnesses Presented by David Davis

1/30/2018 ALZ123 The basics of Alzheimers and other dementia-related illnesses Presented by David Davis STATISTICS A NATIONAL CRISIS Approximately 50,000 in New Mexico Currently there is no treatment, cure or preventive for

493 views • 5 slides

AlzPED Rigor, Reproducibility, Transparency Cindy Sheffield Project Manager AlzPED

AlzPED Rigor, Reproducibility, Transparency Cindy Sheffield Project Manager AlzPED Zimmerman Associates, Inc. SLA Annual Conference Phoenix, AZ June, 2017 Alzheimers Disease: Research and Impact AlzPED Goals Provide

484 views • 20 slides

Anaerobic Digestion 101 November 2, 2017 1:00 3:00 pm Eastern WEF Plant Operations and

Anaerobic Digestion 101 November 2, 2017 1:00 3:00 pm Eastern WEF Plant Operations and Maintenance Committee How to Participate Today Audio Modes Listen using Mic & S peakers Or, select Use Telephone and dial

859 views • 57 slides

A Powered Up Anaerobic Digester Lessons Learned in Energy Optimization MWEA

A Powered Up Anaerobic Digester Lessons Learned in Energy Optimization MWEA Administrators Conference January 2013 Rich Grant, P.E. Fleis & VandenBrink Engineering Proposed Agenda Background Goals - Net Gain

457 views • 31 slides

Anaerobic Digestion & Biogas Technology within UK Agriculture Greenfinch Ltd GREENFINCH LTD

Anaerobic Digestion & Biogas Technology within UK Agriculture Greenfinch Ltd GREENFINCH LTD Based in Ludlow, south Shropshire. Specialise in anaerobic digestion. 8 years of R&D into the AD of food waste. Constructed 7

691 views • 33 slides

Development for Thurston County Phase 1: South County Community Digester Project Opportunities

Clean Energy Development for Thurston County Phase 1: South County Community Digester Project Opportunities Update: May 9, 2016 Public Meeting Monday, May 9, 2016 - Introduction - Outcomes and Results - Next steps Presenter and AD-TAG

673 views • 42 slides

Biogas production assessment for a semi-continuous anaerobic co- digestion pilot plant J.

Biogas production assessment for a semi-continuous anaerobic co- digestion pilot plant J. Mosquera1, W. Beltran1, N.D. Alvarez1, S.D. Nova2, A. Santis 2, P. Acevedo1,2, I. Cabeza1,3 1 Department of Environmental Engineering, Universidad Santo

631 views • 15 slides